Damon Joe (@damon987)

Yeni makale yazdı

4 yıllar önce ·çevirmek

Biopreservation Media Providers Market, By Roots Analysis | #biopreservation market # Biopreservation Market growth # Biopreservation Market Size # Biopreservation Media Providers Market

Haberler ve Politika

Biopreservation Media Providers Market, By Roots Analysis

North America emerged as a key hub for companies offering biopreservation media, featuring the presence of more than 65% the providers

Yorum Yap

Yeni makale yazdı

4 yıllar önce ·çevirmek

Oligonucleotide Synthesis, Modification and Purification Services Market, By Roots Analysis | #oligonucleotide Synthesis Market # Oligonucleotide Synthesis Market Size # Oligonucleotide Synthesis Market share # Oligonucleotide Synthesis Market Growth

Haberler ve Politika

Oligonucleotide Synthesis, Modification and Purification Services Market, By Roots Analysis

Since the approval of the first antisense drug in 1998, oligonucleotides have paved their way into the therapeutic segment,

Yorum Yap

Yeni makale yazdı

4 yıllar önce ·çevirmek

Organ-based / Targeted Drug Delivery Devices Market for Biologics | #targeted Drug Delivery Devices Market # targeted drug delivery system devices # targeted drug delivery # targeted drug delivery device market growth

Haberler ve Politika

Organ-based / Targeted Drug Delivery Devices Market for Biologics

Given the rapid pace of growth within the biopharmaceutical market, the demand for effective delivery systems is anticipated to increase in the foreseen future.

Yorum Yap

Yeni makale yazdı

4 yıllar önce ·çevirmek

Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031 | #squamous non-small cell lung cancer # non-small cell lung cancer # lung cancer therapeutics market #squamous cell carcinoma

Haberler ve Politika

Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031

More than 78% of the therapies are being evaluated in early stages, either as monotherapies or in combination with other products.

Yorum Yap

Yeni makale yazdı

4 yıllar önce ·çevirmek

Haberler ve Politika

Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031

More than 78% of the therapies are being evaluated in early stages, either as monotherapies or in combination with other products.

Yorum Yap